Patents by Inventor Miriam Reuschenbach

Miriam Reuschenbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer
    Patent number: 10682402
    Abstract: Described is a vaccine for prevention and treatment of cancer characterized by microsatellite instability (MSI). The vaccine contains an MSI-specific frameshift peptide (FSP) generating humoral and cellular responses against tumor cells or a nucleic acid encoding said FSP. The vaccine of the present invention is particularly useful for the prevention/treatment of colorectal cancer, endometrial cancer, gastric cancer or small bowel cancer.
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: June 16, 2020
    Assignee: Ruprecht-Karls-Universität Heidelberg
    Inventors: Matthias Kloor, Miriam Reuschenbach, Magnus von Knebel-Doeberitz
  • MSI-SPECIFIC FRAMESHIFT PEPTIDES (FSP) FOR PREVENTION AND TREATMENT OF CANCER
    Publication number: 20170340717
    Abstract: Described is a vaccine for prevention and treatment of cancer characterized by microsatellite instability (MSI). The vaccine contains an MSI-specific frameshift peptide (FSP) generating humoral and cellular responses against tumor cells or a nucleic acid encoding said FSP. The vaccine of the present invention is particularly useful for the prevention/treatment of colorectal cancer, endometrial cancer, gastric cancer or small bowel cancer.
    Type: Application
    Filed: July 31, 2017
    Publication date: November 30, 2017
    Inventors: Matthias Kloor, Miriam Reuschenbach, Magnus von Knebel-Doeberitz
  • MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer
    Patent number: 9770499
    Abstract: Described is a vaccine for prevention and treatment of cancer characterized by microsatellite instability (MSI). The vaccine contains an MSI-specific frameshift peptide (FSP) generating humoral and cellular responses against tumor cells or a nucleic acid encoding said FSP. The vaccine of the present invention is particularly useful for the prevention/treatment of colorectal cancer, endometrial cancer, gastric cancer or small bowel cancer.
    Type: Grant
    Filed: October 29, 2015
    Date of Patent: September 26, 2017
    Assignee: Ruprecht-Karls-Universitat Heidelberg
    Inventors: Matthias Kloor, Miriam Reuschenbach, Magnus von Knebel-Doeberitz
  • p16derived peptides for prophylaxis and therapy of HPV-associated tumors and other p16expressing tumors
    Patent number: 9566319
    Abstract: Described are particular fragments of the cyclin-dependent kinase inhibitor p16 capable of increasing IFN-? secretion of T cells or inducing proliferation of T cells and the use of said fragments for immunizing an individual against HPV-associated or other p16INK4a expressing carcinomas, preferably advanced carcinomas.
    Type: Grant
    Filed: July 15, 2015
    Date of Patent: February 14, 2017
    Assignee: Ruprecht-Karls-Universitaet Heidelberg
    Inventors: Matthias Kloor, Miriam Reuschenbach, Magnus Von Knebel-Doeberitz
  • MSI-SPECIFIC FRAMESHIFT PEPTIDES (FSP) FOR PREVENTION AND TREATMENT OF CANCER
    Publication number: 20160038579
    Abstract: Described is a vaccine for prevention and treatment of cancer characterized by microsatellite instability (MSI). The vaccine contains an MSI-specific frameshift peptide (FSP) generating humoral and cellular responses against tumor cells or a nucleic acid encoding said FSP. The vaccine of the present invention is particularly useful for the prevention/treatment of colorectal cancer, endometrial cancer, gastric cancer or small bowel cancer.
    Type: Application
    Filed: October 29, 2015
    Publication date: February 11, 2016
    Inventors: Matthias Kloor, Miriam Reuschenbach, Magnus von Knebel-Doeberitz
  • MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer
    Patent number: 9205140
    Abstract: Described is a vaccine for prevention and treatment of cancer characterized by microsatellite instability (MSI). The vaccine contains an MSI-specific frameshift peptide (FSP) generating humoral and cellular responses against tumor cells or a nucleic acid encoding said FSP. The vaccine of the present invention is particularly useful for the prevention/treatment of colorectal cancer, endometrial cancer, gastric cancer or small bowel cancer.
    Type: Grant
    Filed: December 13, 2012
    Date of Patent: December 8, 2015
    Assignee: Ruprecht-Karls-Universität
    Inventors: Matthias Kloor, Miriam Reuschenbach, Magnus von Knebel-Doeberitz
  • P16INK4A DERIVED PEPTIDES FOR PROPHYLAXIS AND THERAPY OF HPV-ASSOCIATED TUMORS AND OTHER P16INK4A EXPRESSING TUMORS
    Publication number: 20150313979
    Abstract: Described are particular fragments of the cyclin-dependent kinase inhibitor p16 capable of increasing IFN-? secretion of T cells or inducing proliferation of T cells and the use of said fragments for immunizing an individual against HPV-associated or other p16INK4a expressing carcinomas, preferably advanced carcinomas.
    Type: Application
    Filed: July 15, 2015
    Publication date: November 5, 2015
    Inventors: Matthias Kloor, Miriam Reuschenbach, Magnus Von Knebel-Doeberitz
  • P16derived peptides for prophylaxis and therapy of HPV-associated tumors and other P16expressing tumors
    Patent number: 9114101
    Abstract: Described are particular fragments of the cyclin-dependent kinase inhibitor p16 capable of increasing IFN-? secretion of T cells or inducing proliferation of T cells and the use of said fragments for immunizing an individual against HPV-associated or other p16INK4a expressing carcinomas, preferably advanced carcinomas.
    Type: Grant
    Filed: December 13, 2012
    Date of Patent: August 25, 2015
    Assignee: RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
    Inventors: Matthias Kloor, Miriam Reuschenbach, Magnus Von Knebel-Doeberitz
  • MSI-SPECIFIC FRAMESHIFT PEPTIDES (FSP) FOR PREVENTION AND TREATMENT OF CANCER
    Publication number: 20140170178
    Abstract: Described is a vaccine for prevention and treatment of cancer characterized by microsatellite instability (MSI). The vaccine contains an MSI-specific frameshift peptide (FSP) generating humoral and cellular responses against tumor cells or a nucleic acid encoding said FSP. The vaccine of the present invention is particularly useful for the prevention/treatment of colorectal cancer, endometrial cancer, gastric cancer or small bowel cancer.
    Type: Application
    Filed: December 13, 2012
    Publication date: June 19, 2014
    Applicant: RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG
    Inventors: Matthias Kloor, Miriam Reuschenbach, Magnus von Knebel-Doeberitz
  • P16INK4A DERIVED PEPTIDES FOR PROPHYLAXIS AND THERAPY OF HPV-ASSOCIATED TUMORS AND OTHER P16INK4A EXPRESSING TUMORS
    Publication number: 20140170179
    Abstract: Described are particular fragments of the cyclin-dependent kinase inhibitor p16 capable of increasing IFN-? secretion of T cells or inducing proliferation of T cells and the use of said fragments for immunizing an individual against HPV-associated or other p16INK4a expressing carcinomas, preferably advanced carcinomas.
    Type: Application
    Filed: December 13, 2012
    Publication date: June 19, 2014
    Applicant: RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG
    Inventors: Matthias KLOOR, Miriam REUSCHENBACH, Magnus VON KNEBEL-DOEBERITZ